CONFIDENTIAL — APPROVED FOR PUBLIC RELEASE · BUREAU FILE COPY RECORDS CURRENT AS OF 29 MAY 2026 · DISTRIBUTION: UNRESTRICTED
VendorInvestigate Independent Testing Bureau · Public Records Division
DOCKET YEAR 2026 · VOL. II
13,421 SAMPLES ON FILE
No fee · No favor
Compound Evidence File
#EC-2026-0307

GHK-CU 2000mcg+Glutathione 200mg+Histidine 100mg+Glycine 50mg+NADH 50mg

Filed under Injectable Oils. The bureau holds 51 laboratory returns for this compound from 15 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.

Cross-Index

Subjects Shipping This Compound

15 SUBJECTS
SubjectGradeSamplesMeanMinMaxFirst seenLast seen
HomopeptideCASE #VI-2026-0760A510.09.910.024 May 202624 May 2026
Tianjin Finder Chemical TFCCASE #VI-2026-0693A69.99.910.014 Nov 202516 Apr 2026
Glbiochem (Shanghai)CASE #VI-2026-0704A39.08.39.923 May 202623 May 2026
Risynth BioCASE #VI-2026-0672X18.78.78.72 Apr 20252 Apr 2025
Shanghai Sigma Audley SSACASE #VI-2026-0486A58.67.69.423 May 202623 May 2026
Nantong Guangyuan Chemical GYCCASE #VI-2026-0284A78.57.010.024 May 202624 May 2026
Shanghai BaojuCASE #VI-2026-0233X28.37.69.12 Jul 202524 May 2026
Qingdao Sigma Chemical QSCCASE #VI-2026-0538A68.27.29.324 May 202624 May 2026
Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594A38.07.88.224 May 202624 May 2026
TSC Top Supplements ChinaCASE #VI-2026-0523X76.65.18.711 Jun 202523 May 2026
Qingdao Hongshengda TradingCASE #VI-2026-0334X15.05.05.011 Jun 202511 Jun 2025
Swiss ChemsCASE #VI-2026-0030X14.74.74.72 Jul 20252 Jul 2025
Peptide GurusCASE #VI-2026-0854X44.02.96.03 Jul 202519 Jan 2026
Guangzhou Lengiuanhuang CosmeticsCASE #VI-2026-0228X12.32.32.324 Apr 202524 Apr 2025
Weifang Xingbei International TradeCASE #VI-2026-0766X10.60.60.68 Jul 20258 Jul 2025

Open any subject to view the batch-level evidence for GHK-CU 2000mcg+Glutathione 200mg+Histidine 100mg+Glycine 50mg+NADH 50mg alone.